Due to its highly disrupted lipid and glucose metabolism and a fasting glycemia levels above 126 mg/dl, the Zucker diabetic rat exhibits a phenotype that has been chosen by several research groups and pharmaceutical companies as an obesity and T2D model [27].
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}